Cohen JA, Cameron MH, Goldman MD, Goodman AD, et al. A Phase 3, double-blind, placebo-controlled efficacy and safety study of ADS-5102 (Amantadine) extended-release capsules in people with multiple sclerosis and walking impairment. Mult Scler 2021 Aug 27:13524585211035333. doi: 10.1177/13524585211035333.
PMID: 34449295